DAPC structural adaption in regulating nanotopography-responsive myotube orientation
DAPC structural adaption in regulating nanotopography-responsive myotube orientation
批准号:
10592954
负责人:
JOACHIM D MUELLER
金额:
$35.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-20 至 2025-08-31
关键词:
AffectAgeBiochemicalBiocompatible MaterialsBrainCellsCessation of lifeCuesCytoskeletonDataDimensionsDiseaseDuchenne muscular dystrophyDystrophinDystrophin-Associated Protein ComplexEngineeringExhibitsExtracellular MatrixFoundationsFutureGenetic DiseasesHeart failureHumanIndividualIntegral Membrane ProteinKnowledgeLamininLateralLengthLinkLocationMechanicsMediatingMicroscopyMuscleMuscle CellsMuscle FibersMuscle functionMuscular DystrophiesMutationMyofibrilsMyopathyNanotopographyNeuromuscular DiseasesOrganOutcomePatientsPatternPhenotypePositioning AttributeProteinsRespiratory FailureRoleSignal TransductionTechnologyTestingTissuesWidthcell behaviordrug developmentimaging modalityinduced pluripotent stem cellinsightmatrigelmechanotransductionnanoarchitecturenanoclusternanoscalenew technologynovelphenotypic biomarkerprotein complexrenal epitheliumresponsesingle moleculesubmicronsuperresolution imagingtherapy developmenttransmission processultra high resolution
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The Dystrophin-Associated-Protein-Complex (DAPC) is an important transmembrane protein complex that
structurally, mechanically, and functionally links cytoskeleton and the extracellular matrix and serves as both
mechanical and signaling hubs in regulating muscle and non-muscle cells. Mutations affecting DAPC
components are associated with a wide range of diseases such as muscular dystrophies. Although there is a
wealth of knowledge on the DAPC composition, the mechanisms underlying how the DAPC senses and adapts
to biochemical, mechanical, and topographic cues in cell microenvironments and consequently regulates cell
phenotypes and functions remain unknown. We recently discovered that substrates patterned with submicron
ridges/grooves and functionalized with Matrigel or laminin present an engineered cell microenvironment to
allow myotubes derived from non-diseased human induced pluripotent stem cells (hiPSCs) to align nearly
perpendicular to the ridges, while myotubes derived from less-affected and severely-affected Duchenne
Muscular Dystrophy (a genetic disorder resulting from mutations in dystrophin and often leading to death at an
age of 20-30s due to cardiac and respiratory failure) cells exhibit prominent differences in alignment and
orientation, providing a sensitive phenotypic biomarker to distinguish these cells, which may serve as a
phenotypic readout for high throughput therapy development. Our preliminary data suggest that this
nanotopography-responsive myotube orientation is regulated by the DAPC; however, details of how
nanotopography regulates myotube orientation through the DAPC are unclear. We hypothesize that the
perpendicular myotube orientation is caused by structural adaption of the anisotropic DAPC on the
nanotopography to remain its stability. We expect that super-resolution Single Molecule Localization
Microscopy (SMLM) will enable us to examine the DAPC nanoarchitecture and its structural adaption in
response to nanotopography and verify our hypothesis. Successful accomplishment of this project will reveal
unprecedented nanoscale details of the DAPC, DAPC structural adaption on nanotopography, and the
mechanism underlying the nanotopography-responsive myotube orientation, which are all unknown currently.
This project will lay the foundation for future studies that combine SMLM and biomaterials engineering to
elucidate more mechanistic details underlying DAPC-mediated force transmission, mechanosensing, and
mechanochemical transduction in normal muscle function and in various muscular and neuromuscular
disorders. Verification of the role of the DAPC in regulating nanotopography-responsive myotube orientation
may extend it as a phenotypic biomarker for many other muscular dystrophies associated with defective DAPC
components. This study will also reveal novel engineering approaches to regulate cell behavior and cell fate
through topographic control of the DAPC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV particle morphology and biogenesis
-
批准号:10772748
-
项目类别:
-
资助金额:$71.21万
-
财政年份:2023
-
负责人:JOACHIM D MUELLER
-
依托单位:
HIV Gag lattice morphology and particle biogenesis - Administrative Supplement
-
批准号:9701541
-
项目类别:
-
资助金额:$17.04万
-
财政年份:2017
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:7937181
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2009
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:6701748
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
In Vivo Fluorescence Fluctuation Spectroscopy
-
批准号:8451340
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
In Vivo Fluorescence Fluctuation Spectroscopy
-
批准号:8237253
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
In Vivo Fluorescence Fluctuation Spectroscopy
-
批准号:8616072
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
In Vivo Fluorescence Fluctuation Spectroscopy
-
批准号:9193132
-
项目类别:
-
资助金额:$8.97万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:7010752
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:7175456
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:6620650
-
项目类别:
-
资助金额:$14.45万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:6799040
-
项目类别:
-
资助金额:$4.95万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:7561055
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:7370064
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:6870930
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
In Vivo Flourescence Fluctuation Spectroscopy
-
批准号:9336933
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:6420115
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
IN VIVO FLUORESCENCE FLUCTUATION SPECTROSCOPY
-
批准号:8033786
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2002
-
负责人:JOACHIM D MUELLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: